busulfan has been researched along with Carcinoma, Renal Cell in 5 studies
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We performed a Phase I and pharmacokinetic study of once-daily, intravenously administered busulfan in the setting of a reduced-intensity preparative regimen and matched sibling donor allogeneic stem cell transplantation for treatment of metastatic renal cell carcinoma." | 2.72 | Phase I and pharmacokinetic study of once-daily dosing of intravenously administered busulfan in the setting of a reduced-intensity preparative regimen and allogeneic hematopoietic stem cell transplantation as immunotherapy for renal cell carcinoma. ( Alexander, W; Bachier, C; LeMaistre, C; Pollack, M; Ririe, D; Shaughnessy, P; Splichal, J; Tran, H, 2006) |
| "Therapy of advanced renal cell carcinoma remains difficult." | 1.30 | [Treosulfan displays cytotoxic effect on spheroids of primary cell cultures of renal cell carcinoma independent of p-glycoprotein expression]. ( Gross, AJ; Hemmerlein, B; Kallerhoff, M; Kugler, A; Ringert, RH; Seseke, F, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Omori, S | 1 |
| Fujioka, T | 1 |
| Ono, Y | 1 |
| Numaoka, H | 1 |
| Ishida, Y | 1 |
| Mertins, SD | 1 |
| Myers, TG | 1 |
| Holbeck, SL | 1 |
| Medina-Perez, W | 1 |
| Wang, E | 1 |
| Kohlhagen, G | 1 |
| Pommier, Y | 1 |
| Bates, SE | 1 |
| Shaughnessy, P | 1 |
| Alexander, W | 1 |
| Tran, H | 1 |
| Ririe, D | 1 |
| Splichal, J | 1 |
| Pollack, M | 1 |
| Bachier, C | 1 |
| LeMaistre, C | 1 |
| Foa, P | 1 |
| Iurlo, A | 1 |
| Maiolo, A | 1 |
| Kugler, A | 1 |
| Hemmerlein, B | 1 |
| Gross, AJ | 1 |
| Seseke, F | 1 |
| Kallerhoff, M | 1 |
| Ringert, RH | 1 |
1 trial available for busulfan and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Phase I and pharmacokinetic study of once-daily dosing of intravenously administered busulfan in the setting of a reduced-intensity preparative regimen and allogeneic hematopoietic stem cell transplantation as immunotherapy for renal cell carcinoma.
Topics: Aged; Area Under Curve; Busulfan; Carcinoma, Renal Cell; Hematopoietic Stem Cell Transplantation; Hu | 2006 |
4 other studies available for busulfan and Carcinoma, Renal Cell
| Article | Year |
|---|---|
[Reduced intensity stem cell transplantation for metastatic renal cell carcinoma].
Topics: Adult; Busulfan; Carcinoma, Renal Cell; Cyclosporine; Fatal Outcome; Female; Graft vs Host Disease; | 2004 |
In vitro evaluation of dimethane sulfonate analogues with potential alkylating activity and selective renal cell carcinoma cytotoxicity.
Topics: Alkylating Agents; Animals; Bromodeoxyuridine; Busulfan; Carcinoma, Renal Cell; Carmustine; Cell Cyc | 2004 |
Renal cancer after busulphan treatment for chronic myeloid leukemia: therapeutic implications.
Topics: Busulfan; Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL P | 1993 |
[Treosulfan displays cytotoxic effect on spheroids of primary cell cultures of renal cell carcinoma independent of p-glycoprotein expression].
Topics: Antineoplastic Agents, Alkylating; Busulfan; Carcinoma, Renal Cell; Cell Survival; Dose-Response Rel | 1998 |